Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

NCT01627704 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Fluoroestradiol (18F)

Sponsor

Assistance Publique - Hôpitaux de Paris